Table 1 Baseline characteristics and outcome of the patients
Variable | Non-infected patients (n = 67) | Infected patients without SIRS (n = 32) | Patients with sepsis (n = 47) | Patients with severe sepsis (n = 27) |
|---|---|---|---|---|
Gender, number (percentage) | ||||
Male | 23 (34.3) | 18 (56.3) | 20 (42.6) | 18 (66.7) |
Female | 44 (65.7) | 14 (43.7) | 27 (57.4) | 9 (33.3) |
Age in years, mean ± SD | 67.3 ± 17.1 | 60.8 ± 16.6 | 60.4 ± 19.9 | 66.4 ± 17.8 |
Length of hospitalisation in days, mean ± SD | 8.5 ± 6.9 | 10.3 ± 11.5 | 7.8 ± 6.7 | 10.8 ± 10.5 |
Mortality on day 28, number (percentage) | 6 (8.9) | 0 | 0 | 4 (14.8) |
Severity of disease, mean ± SD | ||||
SOFA score | 1.4 ± 1.1 | 1.6 ± 1.5 | 1.6 ± 1.2 | 3.0 ± 1.9 |
Comorbidity, mean ± SD | ||||
Charlson Index | 1.6 ± 1.3 | 1.3 ± 1.3 | 1.1 ± 1.3 | 1.2 ± 1.3 |
Laboratory findings, mean ± SD | ||||
Haemoglobin, mmol/l | 8.1 ± 1.1 | 8.2 ± 1.2 | 8.2 ± 1.2 | 8.2 ± 1.1 |
Platelet count, 109/l | 288.5 ± 108.2 | 324.5 ± 210.6 | 254.4 ± 107.3 | 268.0 ± 184.4 |
Bilirubin, μmol/l | 9.3 ± 6.9 | 21.9 ± 36.6 | 10.6 ± 6.8 | 13.6 ± 5.5 |
Prothrombin time (reference: 0.70–1.30) | 1.0 ± 0.3 | 0.9 ± 0.4 | 0.9 ± 0.3 | 0.9 ± 0.3 |
Creatinine, μmol/l | 96.7 ± 27.3 | 100.6 ± 31.2 | 100.4 ± 31.7 | 140.3 ± 79.5 |